Trasplante simultáneo de páncreas y riñon en diabetes mellitus tipo 1: Experiencia de un centro en Chile

Background: Simultaneous kidney and páncreas transplantation (SKPT) is the best alternative for end stage renal disease among patients with insulin dependent diabetes mellitus. Aim: To report our experience with SKPT. Material andMethods: Retrospective analysis ofl2 recipients of SKPT transplanted i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: ALBA,ANDREA, MORALES,JORGE, FERRARIO,MARIO, ZEHNDER,CARLOS, AGUILÓ,JORGE, ZAVALA,CARLOS, HERZOG,CRISTINA, CALABRAN,LORENA, CONTRERAS,LUIS, ESPINOZA,RICARDO, BUCKEL,ERWIN, FIERRO,JUAN ALBERTO
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2011
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011000100002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872011000100002
record_format dspace
spelling oai:scielo:S0034-988720110001000022011-04-11Trasplante simultáneo de páncreas y riñon en diabetes mellitus tipo 1: Experiencia de un centro en ChileALBA,ANDREAMORALES,JORGEFERRARIO,MARIOZEHNDER,CARLOSAGUILÓ,JORGEZAVALA,CARLOSHERZOG,CRISTINACALABRAN,LORENACONTRERAS,LUISESPINOZA,RICARDOBUCKEL,ERWINFIERRO,JUAN ALBERTO Kidney transplantation Organ transplantation Páncreas transplantation Background: Simultaneous kidney and páncreas transplantation (SKPT) is the best alternative for end stage renal disease among patients with insulin dependent diabetes mellitus. Aim: To report our experience with SKPT. Material andMethods: Retrospective analysis ofl2 recipients of SKPT transplanted in one center starting in 1994, with a meanfollow-upperiod of6.8years (2-15). Results: Eleven ofl2 recipients were in chronic hemodialysis before SKPT. Mean A, B, DR and HLA mismatch was 4.3. Mean preformed anti HLA antibodies was 3.3 %. Mean cold ischemia times for páncreas and kidney were 6 and 10 hours, respectively. In the first eight cases, the páncreas was drained to the bladder, and in the last four, an enteric drainage was performed. Eleven recipients were induced with antibodies, and maintenance immunosuppression consisted ofCyclosporine or Tacrolimusplus an antiproliferative agent. Ten year patient survival was 70 %. Páncreas and kidney survival, defined by insulin and dialysis independence, were 72 and 73% respectively. Fifty percent of recipients experienced acute graft rejection (cellular or humoral), with good response to treatment except in one case. Conclusions: This experience shows that SKPT is associated with an excellent patient survival associated to insulin and dialysis independence in 70% of patients at 10 years.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.139 n.1 20112011-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011000100002es10.4067/S0034-98872011000100002
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Kidney transplantation
Organ transplantation
Páncreas transplantation
spellingShingle Kidney transplantation
Organ transplantation
Páncreas transplantation
ALBA,ANDREA
MORALES,JORGE
FERRARIO,MARIO
ZEHNDER,CARLOS
AGUILÓ,JORGE
ZAVALA,CARLOS
HERZOG,CRISTINA
CALABRAN,LORENA
CONTRERAS,LUIS
ESPINOZA,RICARDO
BUCKEL,ERWIN
FIERRO,JUAN ALBERTO
Trasplante simultáneo de páncreas y riñon en diabetes mellitus tipo 1: Experiencia de un centro en Chile
description Background: Simultaneous kidney and páncreas transplantation (SKPT) is the best alternative for end stage renal disease among patients with insulin dependent diabetes mellitus. Aim: To report our experience with SKPT. Material andMethods: Retrospective analysis ofl2 recipients of SKPT transplanted in one center starting in 1994, with a meanfollow-upperiod of6.8years (2-15). Results: Eleven ofl2 recipients were in chronic hemodialysis before SKPT. Mean A, B, DR and HLA mismatch was 4.3. Mean preformed anti HLA antibodies was 3.3 %. Mean cold ischemia times for páncreas and kidney were 6 and 10 hours, respectively. In the first eight cases, the páncreas was drained to the bladder, and in the last four, an enteric drainage was performed. Eleven recipients were induced with antibodies, and maintenance immunosuppression consisted ofCyclosporine or Tacrolimusplus an antiproliferative agent. Ten year patient survival was 70 %. Páncreas and kidney survival, defined by insulin and dialysis independence, were 72 and 73% respectively. Fifty percent of recipients experienced acute graft rejection (cellular or humoral), with good response to treatment except in one case. Conclusions: This experience shows that SKPT is associated with an excellent patient survival associated to insulin and dialysis independence in 70% of patients at 10 years.
author ALBA,ANDREA
MORALES,JORGE
FERRARIO,MARIO
ZEHNDER,CARLOS
AGUILÓ,JORGE
ZAVALA,CARLOS
HERZOG,CRISTINA
CALABRAN,LORENA
CONTRERAS,LUIS
ESPINOZA,RICARDO
BUCKEL,ERWIN
FIERRO,JUAN ALBERTO
author_facet ALBA,ANDREA
MORALES,JORGE
FERRARIO,MARIO
ZEHNDER,CARLOS
AGUILÓ,JORGE
ZAVALA,CARLOS
HERZOG,CRISTINA
CALABRAN,LORENA
CONTRERAS,LUIS
ESPINOZA,RICARDO
BUCKEL,ERWIN
FIERRO,JUAN ALBERTO
author_sort ALBA,ANDREA
title Trasplante simultáneo de páncreas y riñon en diabetes mellitus tipo 1: Experiencia de un centro en Chile
title_short Trasplante simultáneo de páncreas y riñon en diabetes mellitus tipo 1: Experiencia de un centro en Chile
title_full Trasplante simultáneo de páncreas y riñon en diabetes mellitus tipo 1: Experiencia de un centro en Chile
title_fullStr Trasplante simultáneo de páncreas y riñon en diabetes mellitus tipo 1: Experiencia de un centro en Chile
title_full_unstemmed Trasplante simultáneo de páncreas y riñon en diabetes mellitus tipo 1: Experiencia de un centro en Chile
title_sort trasplante simultáneo de páncreas y riñon en diabetes mellitus tipo 1: experiencia de un centro en chile
publisher Sociedad Médica de Santiago
publishDate 2011
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011000100002
work_keys_str_mv AT albaandrea trasplantesimultaneodepancreasyrinonendiabetesmellitustipo1experienciadeuncentroenchile
AT moralesjorge trasplantesimultaneodepancreasyrinonendiabetesmellitustipo1experienciadeuncentroenchile
AT ferrariomario trasplantesimultaneodepancreasyrinonendiabetesmellitustipo1experienciadeuncentroenchile
AT zehndercarlos trasplantesimultaneodepancreasyrinonendiabetesmellitustipo1experienciadeuncentroenchile
AT aguilojorge trasplantesimultaneodepancreasyrinonendiabetesmellitustipo1experienciadeuncentroenchile
AT zavalacarlos trasplantesimultaneodepancreasyrinonendiabetesmellitustipo1experienciadeuncentroenchile
AT herzogcristina trasplantesimultaneodepancreasyrinonendiabetesmellitustipo1experienciadeuncentroenchile
AT calabranlorena trasplantesimultaneodepancreasyrinonendiabetesmellitustipo1experienciadeuncentroenchile
AT contrerasluis trasplantesimultaneodepancreasyrinonendiabetesmellitustipo1experienciadeuncentroenchile
AT espinozaricardo trasplantesimultaneodepancreasyrinonendiabetesmellitustipo1experienciadeuncentroenchile
AT buckelerwin trasplantesimultaneodepancreasyrinonendiabetesmellitustipo1experienciadeuncentroenchile
AT fierrojuanalberto trasplantesimultaneodepancreasyrinonendiabetesmellitustipo1experienciadeuncentroenchile
_version_ 1718436545614053376